Catalent to Acquire Pharmatek
PTSM: Pharmaceutical Technology Sourcing and Management
Catalent will acquire Pharmatek, a San Diego-based manufacturer of oral, injectable, and topical products.
On Sept. 13, 2016, Catalent Pharma Solutions announced its plans to acquire Pharmatek Laboratories, a California-based manufacturer of oral, injectable, and topical products. No financial terms of the agreement have been disclosed.
The acquisition of Pharmatek will add spray drying to Catalent’s portfolio of drug formulation and delivery technologies and expand their capability for handling highly potent compounds. Pharmatek offers a drug-development platform including formulation screening, formulation development, analytical services, and finished-dose-form manufacturing for clinical supply. The company also offers solutions for poorly soluble compounds, controlled release formulations, and facilities for potent compound handling.
Pharmatek’s San Diego facility contains two analytical and two formulation laboratories, four engineering rooms, and nine certified ISO Class 8 manufacturing suites. Catalent says they expect the transaction to close within the new few weeks and that the company will pay all cash in the acquisition.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
